Company intelligence / Profile preview

i-SENS

Seoul, Seoul, South Koreai-sens.com ↗

Ownership: Private
Development stage: Commercial

Overview

i-SENS is the market leader in Korea for blood glucose monitoring systems, with global reach in over 110 countries. Its flagship CareSens line includes self-monitoring blood glucose meters and continuous glucose monitoring systems. The company has launched Korea’s first domestically developed CGM system, CareSens Air, which received CE certification for European markets in 2024.

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: DeviceDiagnostic reagent
Industry: Metabolite Diagnostics

Partnerships

AgaMatrix Inc. – strategic supply agreement for test strips and international expansion partner since early 2000s

Beyond the preview

Go deeper on i-SENS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-SENS.

Explore the full profile